Excessive angiogenesis associated with psoriasis as a cause for cardiovascular ischaemia

Nina Malecic1, Helen S Young1

  • 1Manchester Academic Health Science Centre, Department of Dermatology, The University of Manchester, Manchester, UK.

Experimental Dermatology
|February 4, 2017
PubMed

Insights

Psoriasis patients show increased angiogenesis, driven by vascular endothelial growth factor (VEGF). This process may link skin disease to cardiovascular events and offer new therapeutic targets.

Area of Science:

  • Dermatology and Cardiovascular Research

Background:

  • Psoriasis affects 2-3% of the UK population, causing significant quality of life impairment.
  • Psoriasis is linked to cardiovascular comorbidity and metabolic syndrome.
  • Angiogenesis is implicated in psoriasis pathogenesis and atherosclerosis development.

Purpose of the Study:

  • To explore the role of vascular endothelial growth factor (VEGF)-mediated angiogenesis in psoriasis.
  • To investigate angiogenesis as a potential marker for systemic vascular pathology in psoriasis patients.
  • To examine VEGF-mediated angiogenesis as a therapeutic target for cardiovascular events in psoriasis.

Main Methods:

  • This viewpoint study reviews existing research on angiogenesis in psoriasis.
  • It focuses on the role of vascular endothelial growth factor (VEGF).

Main Results:

  • Vascular endothelial growth factor (VEGF) is upregulated in psoriasis.
  • Pathological angiogenesis, mediated by VEGF, is a key factor in psoriasis.
  • Cutaneous angiogenesis may serve as a marker for systemic vascular pathology.

Conclusions:

  • VEGF-mediated angiogenesis is a significant factor in psoriasis.
  • It may contribute to cardiovascular events in psoriasis patients.
  • Targeting angiogenesis presents a novel therapeutic avenue for psoriasis and associated cardiovascular conditions.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
519
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
851
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
633
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K